| Lapatinib (Tykerb, GW572016) reverses multidrug resistance in cancer cells by inhibiting the activity of ATP-binding cassette subfamily B member 1 and G member 2 C Dai, AK Tiwari, CP Wu, X Su, SR Wang, D Liu, CR Ashby Jr, Y Huang, ... Cancer research 68 (19), 7905-7914, 2008 | 429 | 2008 |
| BCR-ABL tyrosine kinase inhibitors in the treatment of Philadelphia chromosome positive chronic myeloid leukemia: a review X An, AK Tiwari, Y Sun, PR Ding, CR Ashby Jr, ZS Chen Leukemia research 34 (10), 1255-1268, 2010 | 409 | 2010 |
| Apatinib (YN968D1) reverses multidrug resistance by inhibiting the efflux function of multiple ATP-binding cassette transporters Y Mi, Y Liang, H Huang, H Zhao, CP Wu, F Wang, L Tao, C Zhang, CL Dai, ... Cancer research 70 (20), 7981-7991, 2010 | 384 | 2010 |
| Amide Bond Bioisosteres: Strategies, Synthesis and Successes S Kumari, A Carmona, AK Tiwari, P Trippier J. Med Chem 63 (21), 12290–12358, 2020 | 336 | 2020 |
| Multidrug resistance proteins (MRPs/ABCCs) in cancer chemotherapy and genetic diseases ZS Chen, AK Tiwari The FEBS journal 278 (18), 3226-3245, 2011 | 331 | 2011 |
| Nilotinib (AMN107, Tasigna®) reverses multidrug resistance by inhibiting the activity of the ABCB1/Pgp and ABCG2/BCRP/MXR transporters AK Tiwari, K Sodani, SR Wang, YH Kuang, CR Ashby Jr, X Chen, ... Biochemical pharmacology 78 (2), 153-161, 2009 | 253 | 2009 |
| Alternatives to Biological Skin in Permeation Studies: Current Trends and Possibilities R Neupane, SHS Boddu, J Renukuntla, RJ Babu, AK Tiwari Pharmaceutics 12 (2), 152, 2020 | 239 | 2020 |
| Revisiting the ABCs of multidrug resistance in cancer chemotherapy AK Tiwari, K Sodani, CL Dai, C R Ashby, ZS Chen Current Pharmaceutical Biotechnology 12 (4), 570-594, 2011 | 233 | 2011 |
| ABC Transporter-Mediated Multidrug-Resistant Cancer H Amawi, HM Sim, AK Tiwari, SV Ambudkar, S Shukla Drug Transporters in Drug Disposition, Effects and Toxicity, 549-580, 2019 | 217 | 2019 |
| m6A modification: recent advances, anticancer targeted drug discovery and beyond Deng LJ, Deng WQ, Fan SR, Chen MF, Qi M, Lyu WY, Qi Q, Tiwari AK, Chen JX ... Molecular Cancer 21 (52), 2022 | 206 | 2022 |
| Cancer chemoprevention through dietary flavonoids: what’s limiting? H Amawi, CR Ashby, AK Tiwari Chinese journal of cancer 36, 1-13, 2017 | 206 | 2017 |
| Sildenafil reverses ABCB1-and ABCG2-mediated chemotherapeutic drug resistance Z Shi, AK Tiwari, S Shukla, RW Robey, S Singh, IW Kim, SE Bates, ... Cancer research 71 (8), 3029-3041, 2011 | 183 | 2011 |
| Sensitization of ABCG2-overexpressing cells to conventional chemotherapeutic agent by sunitinib was associated with inhibiting the function of ABCG2 C Dai, Y Liang, Y Wang, AK Tiwari, Y Yan, F Wang, Z Chen, X Tong, L Fu Cancer letters 279 (1), 74-83, 2009 | 145 | 2009 |
| Nilotinib potentiates anticancer drug sensitivity in murine ABCB1-, ABCG2-, and ABCC10-multidrug resistance xenograft models AK Tiwari, K Sodani, C Dai, AH Abuznait, S Singh, ZJ Xiao, A Patel, ... Cancer letters 328 (2), 307-317, 2013 | 127 | 2013 |
| Lapatinib and erlotinib are potent reversal agents for MRP7 (ABCC10)-mediated multidrug resistance YH Kuang, T Shen, X Chen, K Sodani, E Hopper-Borge, AK Tiwari, ... Biochemical pharmacology 79 (2), 154-161, 2010 | 120 | 2010 |
| Resveratrol Loaded Nanomedicines for Cancer Applications M Annaji, I Poudel, SHS Boddu, RD Arnold, AK Tiwari, RJ Babu Cancer Reports 4 (3), 2021 | 97 | 2021 |
| Polyphenolic nutrients in cancer chemoprevention and metastasis: Role of the epithelial-to-mesenchymal (EMT) pathway H Amawi, CR Ashby Jr, T Samuel, R Peraman, AK Tiwari Nutrients 9 (8), 911, 2017 | 97 | 2017 |
| The phosphodiesterase-5 inhibitor vardenafil is a potent inhibitor of ABCB1/P-glycoprotein transporter PR Ding, AK Tiwari, S Ohnuma, JWKK Lee, X An, CL Dai, QS Lu, S Singh, ... PloS one 6 (4), e19329, 2011 | 93 | 2011 |
| The phosphodiesterase-5 inhibitor vardenafil is a potent inhibitor of ABCB1/P-glycoprotein transporter PR Ding, AK Tiwari, S Ohnuma, JWKK Lee, X An, CL Dai, QS Lu, S Singh, ... PloS one 6 (4), e19329, 2011 | 93 | 2011 |
| Imatinib and nilotinib reverse multidrug resistance in cancer cells by inhibiting the efflux activity of the MRP7 (ABCC10) T Shen, YH Kuang, CR Ashby Jr, Y Lei, A Chen, Y Zhou, X Chen, ... PLoS One 4 (10), e7520, 2009 | 87 | 2009 |
Zhe-Sheng ChenCollege of Pharmacy and Health Sciences, St. John's University在 stjohns.edu 的电子邮件经过验证
